Development of a chronic disease indicator score using a Veterans Affairs Medical Center medication database. IMPROVE Investigators.
about
Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications.Comparison of pharmacy-based and diagnosis-based comorbidity measures from medical administrative data.Comparison of Rx-defined morbidity groups and diagnosis- based risk adjusters for predicting healthcare costs in Taiwan.Identifying Depressed Patients With a High Risk of Comorbid Anxiety in Primary Care.Comparison of 3 Depression Screening Methods and Provider Referral in a Veterans Affairs Primary Care ClinicEffectiveness of collaborative care depression treatment in Veterans' Affairs primary care.Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool.Oseltamivir prescribing in pharmacy-benefits database, United States, 2004-2005.The influence of socio-economic status and multimorbidity patterns on healthcare costs: a six-year follow-up under a universal healthcare system.Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project.Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events.Methods to control the pharmaceutical cost impact of chronic conditions in the elderly.Clinical effectiveness of using an integrated model to treat depressive symptoms in veterans affairs primary care clinics and its impact on health care utilization.Development and validation of a diabetes mellitus severity index: a risk-adjustment tool for predicting health care resource use and costs.Co-prescribing of medications used to treat obstructive lung disease, congestive heart failure and depression among users of topical beta blockers: estimates from three US Veterans Affairs Medical Centers.An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical COff-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence.Assessing and predicting drug-induced anticholinergic risks: an integrated computational approach.Comparing antidepressant treatment patterns in older and younger adults: a claims database analysis.
P2860
Q30686074-2DE73A70-1427-493F-9201-4D5D30B58C55Q31146532-B9FA8A29-DDD3-4C7F-90FA-68BA94C8FB09Q33579539-A4453D93-9AD7-4E24-BD0D-AA6111BBF78DQ33778928-79997040-6625-477D-91BE-CC3BBB691140Q34323884-49ABBDA6-121A-4FC4-A049-5D567A4CE9A3Q34740855-479049FA-2093-4B26-A71E-C791D93EBC03Q34811670-A445F26F-E8FF-4AB3-8FE5-5FC4CAF70F9AQ37009614-21334EC1-9B12-4A47-BC41-208E2E81F5A1Q37152097-42B85265-9E03-40FF-BC8B-748C76A35950Q37832209-26A25B4E-AA18-408E-B138-8ABBF095B79EQ38086176-8C9FED24-80D8-4482-B862-99128F247240Q38363812-5942129E-61B7-4318-915D-F65BE3AFA784Q39205295-C7B55515-DF22-4964-8F36-B177868EDB11Q44052415-0005ACDB-8ACF-4B85-AAD1-B1288143AC05Q45334139-36B88E10-305C-4F75-A9C6-94FBC0D37735Q45334479-1A2774F0-5702-4471-8EFD-C0FD8A3DDC07Q47421577-CC197863-69B9-43D9-8966-8EFD2A4668F8Q47679183-41DFB437-DF8F-4A19-B390-A886E5BECB71Q48835482-CDB3CBD6-F454-42D4-AA98-B1C7C1E71D59
P2860
Development of a chronic disease indicator score using a Veterans Affairs Medical Center medication database. IMPROVE Investigators.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Development of a chronic disea ...... tabase. IMPROVE Investigators.
@ast
Development of a chronic disea ...... tabase. IMPROVE Investigators.
@en
type
label
Development of a chronic disea ...... tabase. IMPROVE Investigators.
@ast
Development of a chronic disea ...... tabase. IMPROVE Investigators.
@en
prefLabel
Development of a chronic disea ...... tabase. IMPROVE Investigators.
@ast
Development of a chronic disea ...... tabase. IMPROVE Investigators.
@en
P2093
P1476
Development of a chronic disea ...... tabase. IMPROVE Investigators.
@en
P2093
P304
P356
10.1016/S0895-4356(99)00029-3
P577
1999-06-01T00:00:00Z